ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Amlan International Becomes Full Operating Owner of Agromex, Strengthening Market Presence in Mexico

CHICAGO, June 27, 2023 (GLOBE NEWSWIRE) -- Amlan® International, the animal nutrition and health business of Oil-Dri® Corporation of America (NYSE: ODC), a global leader in mineral science for over 80 years, is pleased to announce the completion of its acquisition of the remaining non-controlling interest of Agromex Importaciones, S.A. de C.V. on May 12, 2023. Amlan now holds 100% ownership of its subsidiary in Mexico, further solidifying its position in the Mexican market.

Oil-Dri initially acquired a majority share in Agromex Importaciones in 2018, establishing a presence in Mexico's animal health industry. Building on this successful partnership, Amlan has taken this strategic step to instill confidence in their customers and leverage the full potential of Agromex to accelerate its growth in the region. This ownership structure reinforces Amlan’s commitment to providing the market with the highest standards of operational excellence as a reliable partner in animal production, offering proven products and superior technical service.

With this acquisition, Agromex will benefit from the leadership of a new Board of Directors consisting of industry experts and seasoned professionals. Dr. Wade Robey, President, Amlan International, and Vice President of Agriculture, Oil-Dri Corporation of America has been appointed as the Chairman of the Board. Dr. Robin Jarquin, Regional Director Latin America, will oversee the operations of Agromex, ensuring a seamless transition and continued success of the subsidiary.

“The poultry industry in Mexico is significant with approximately 46 million broilers processed weekly. Although a substantial portion of the poultry industry in Mexico already uses mycotoxin binders, tremendous growth is still possible. With rising feed prices, at times uncertain grain quality, and the consumers’ desire to remove antibiotics when possible, the products in our portfolio can deliver real value to producers. With this recent change of Agromex’s ownership and sales strategy, we expect to grow Amlan’s business in Mexico rapidly over the next three years,” said Dr. Robin Jarquin.

Agromex will maintain its core focus on selling Amlan’s portfolio of innovative feed additives including Varium® and NeoPrime®, our patented formulations designed to promote efficiency for poultry and swine; Phylox®, a natural alternative to anticoccidial drugs and vaccines; Calibrin® -Z to defend against a broad spectrum of biotoxins; and Calibrin® -A to rapidly bind aflatoxin. By leveraging mineral technology, our products optimize intestinal health to help enhance animal performance, productivity, and overall well-being.

“We are excited about the prospects this acquisition brings and are eager to further strengthen the relationship with our customers in Mexico,” said Heath Wessels, Vice President of Sales, the Americas. The combined expertise and resources of Amlan, Oil-Dri and Agromex will contribute to the continued success and growth of our business in Mexico.

Product availability may vary by country. Associated claims do not constitute medical claims and may differ based on government requirements.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c3305a48-09e8-4fd2-9b24-fb3c6a91eacc


Media Contact
Reagan Culbertson
VP, Strategic Marketing
Press@amlan.com

Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.